Thromb Haemost 1969; 22(03): 450-465
DOI: 10.1055/s-0038-1651428
Originalarbeiten-Original Articles-Travaux Originaux
Schattauer GmbH

Platelet Reactions and Immune Processes

I. Activation of Complement by Several Platelet-Activating Surfaces when Coated with Gammaglobulin; Mechanism of Complement Fixation
F Jobin
1   Départment de biochimie, Faculté de Médecine, Université Laval and the Service d’Hématologie, Hôpital du Saint-Sacrement, Québec
,
F Tremblay
1   Départment de biochimie, Faculté de Médecine, Université Laval and the Service d’Hématologie, Hôpital du Saint-Sacrement, Québec
› Author Affiliations
Supported by research grants from the Medical Research Council of Canada (MA-2342) and from the Conseil de la recherche médicale du Québec.
Further Information

Publication History

Publication Date:
10 June 2018 (online)

Summary

We have studied the interaction between gammaglobulin, complement and several surfaces, in view of gaining a better insight into the molecular mechanisms of the platelet-surface interaction :

1. Glass, polystyrene latex, carbon, kaolin and celite particles are known platelet-activating surfaces. All these surfaces activated complement when coated with gammaglobulin. Collagen however did not show complement fixing ability.

2. Bentonite and betamethasone acetate particles also fixed complement when coated with gammaglobulin.

3. The mechanism of complement fixation induced by these various surface-gammaglobulin complexes was found to be very similar to the reactions induced when immune complexes fix complement.

4. The diverse mechanisms of activation of IgG molecules and the various biological and immunochemical properties of activated IgG are reviewed and discussed.

5. The view is presented that many non-immune as well as immune activators of platelet reactions have in common the ability to activate complement; the possible significance of this property and the role of IgG activation in the induction of platelet reactions are discussed.

 
  • References

  • 1 Mustard J. F, Glynn M. F, Nishizawa E. E, Packham M. A. Platelet-surface interactions: relationship to thrombosis and hemostasis. Fed. Proc. 26: 106 1967;
  • 2 Markwardt F. Studies on the release of biogenic amines from blood platelets. In: Biochemistry of blood Platelets. Edited by Kowalski E, and Niewiarowski S. 105. Academic Press; London: 1967
  • 3 Wright H. P. The adhesiveness of blood platelets in normal subjects with varying concentrations of anticoagulants. J. Path. Bact. 53: 255 1941;
  • 4 Hartmann B. G. Platelet adhesiveness : the retention of platelets on glass surfaces. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl.26: 281 1967;
  • 5 O’Brien J. R, Heywood J. B. Some interactions between human platelets and glass: von Willebrand’s disease compared with normal. J. clin. Path. 20: 56 1967;
  • 6 Pegrum G. D, Shaw S, Wolff S. E. Measurement of platelet adhesiveness including the use of diatomaceous silica (celite). J. clin. Path. 20: 65 1967;
  • 7 Evans G, Mustard J. F. Platelet-surface reaction and thrombosis. Surgery 64: 273 1968;
  • 8 Morris G. D. W. Observations on the effect of glass beads on platelet aggregation and its relation to platelet stickiness. Thrombos. Diathes. haemorrh. (Stuttg.) 20: 345 1968;
  • 9 Glynn M. F, Movat H. Z, Murphy E. A, Mustard J. F. Study of platelet adhesiveness and aggregation with latex particles. J. Lab. clin. Med. 65: 179 1965;
  • 10 Glynn M. F, Herren R, Mustard J. F. Adherence of latex particles to platelets. Nature (Lond.) 212: 79 1966;
  • 11 Movat H. Z, Weiser W. J, Glynn M. F, Mustard J. F. Platelet phagocytosis and aggregation. J. Cell Biol. 27: 531 1965;
  • 12 Horowitz H. I, Papayoanou M. F. Activation of platelet factor 3 by adenosine-5-diphos-phate. Thrombos. Diathes. haemorrh. (Stuttg.) 19: 18 1968;
  • 13 Erichson R. B. Platelet adhesion: morphologic observations. J. exp. Biol. (N.Y.) 3: 7 1968;
  • 14 Hardisty R. M, Dormandy K. M, Hutton R. A. Thrombasthenia. Studies on three cases. Brit. J. Haemat. 10: 371 1964;
  • 15 Hardisty R. M, Hutton R. A. The Kaolin clotting time of platelet-rich plasma: a test of platelet factor 3 availability. Brit. J. Haemat. 11: 258 1965;
  • 16 Spaet T. H, Gintron J. Studies on platelet factor 3 availability. Brit. J. Haemat. 11: 269 1965;
  • 17 Horowitz H. I. Platelet factor 3 activation by celite powder. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl. 17: 113 1965;
  • 18 Packham M. A, Nishizawa E. E, Mustard J. F. Response of platelets to tissue injury. Bio-chem. Pharmacol. Suppl.: 171 1968;
  • 19 Glynn M. F, Packham M. A, Hirsh J, Mustard J. F. The protein requirement for platelet surface reaction. J. clin. Invest. 45: 1013 1966;
  • 20 Mueller-Eckhardt C, Lüscher E. F. Immune reactions of human blood platelets. II. The effect of latex particles coated with gammaglobulin in relation to complement activation. Thrombos. Diathes. haemorrh. (Stuttg.) 20: 168 1968;
  • 21 Evans G, Mustard J. F. Platelet surface reaction and its relation to thrombosis in vascular prosthesis. Canad. med. Ass. J. 98: 119 1969;
  • 22 Mueller-Eckhardt G, Lüscher E. F. Immune reactions of human blood platelets. I. A comparative study on the effects on platelets of heterologous antiplatelet antiserum, antigen-antibody complexes, aggregated gammaglobulin and thrombin. Thrombos. Diathes. haemorrh. (Stuttg.) 20: 155 1968;
  • 23 Jobin F. La fixation du complément par des surfaces étrangères. Un. méd. Can. 96: 1574 1967;
  • 24 Jobin F, Tremblay F. Complement fixation induced by surface-gammaglobulin interaction. In: Abstracts of the Simultaneous Sessions, XIIth Congress of the International Society of Hematology. 140. Edited by Jaffe E. R. New York: 1968
  • 25 Goodman H. C, Bozicevich J. Recently developed techniques for the use of inert particles to detect antigen-antibody reactions. In: Immunological methods. Edited by Ackroyd J. F. 93. Blackwell Scientific Publications; Oxford: 1964
  • 26 Christian C. L. Characterization of the “reactant” (gammaglobulin factor) in the F.II precipitin reaction and the F.II tanned sheep cell agglutination test. J. exp. Med. 108: 139 1958;
  • 27 Kabat E. A, Mayer M. M. Experimental immuno chemistry. 133. Charles C. Thomas Publisher; Springfield, Illinois: 1961
  • 28 Nelson R. A, Jensen J, Gigli I, Tamura N. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea pig serum. Immuno-chemistry 3: 111 1966;
  • 29 Nelson R. A. The role of complement in immune phenomena. In: The Inflammatory Process. Edited by Zweifach B. W, Grant L, and McCluskey R. T. 819. Academic Press Inc.; New York and London: 1965
  • 30 Klein P. G, Wellensiek H. J. Multiple nature of the third component of guinea-pig complement. I. Separation and characterization of three factors a, b and c, essential for haemolysis. Immunology 8: 590 1965;
  • 31 Borsos T, Rapp H. J, Mayer M. M. Studies on the second component of complement. I. The reaction between EAC’14 and C’2: evidence of the single site mechanism of immune hemolysis and determination of C’2 on a molecular basis. J. Immunol. 87: 310 1961;
  • 32 Jobin F, Tremblay F. Platelet reactions and immune processes. IV. The inhibition of complement by pyrazole compounds and other inhibitors of platelet reactions. (Manuscript in preparation).
  • 33 Borsos T, Rapp H. J. Hemolysin titration based on fixation of the activated first component of complement : evidence that one molecule of hemolysin suffices to sensitize an erythrocyte. J. Immunol. 95: 559 1965;
  • 34 Mayer M. M, Osier A. G, Bier O. G, Heidelberger M. Quantitative studies of complement fixation. I. A method. J. Immunol. 59: 195 1948;
  • 35 Ishizaka T, Ishizaka K. Biological activities of aggregated gammaglobulin. I. Skin reactive and complement-fixing properties of heat denatured gammaglobulin. Proc. Soc. exp. Biol. (N. Y.) 101: 845 1959;
  • 36 Ishizaka T, Ishizaka K, Borsos T. Biological activity of aggregated gammaglobulin. IV. Mechanism of complement fixation. J. Immunol. 87: 433 1961;
  • 37 Mayer M. M. Studies on the mechanism of hemolysis by antibody and complement. Progr. Allergy 5: 215 1958;
  • 38 Pillemer L, Seifter S, Ecker E. E. The role of the components of complements in specific immune fixation. J. exp. Med. 75: 421 1942;
  • 39 Lepow I. H, Wurz L, Ratnojf O. D, Pillemer L. Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C’1 and the role of Ca++ . J. Immunol. 73: 146 1954;
  • 40 Marcus D. M. A study of the mechanism of the anticomplementary activity of gammaglobulin. J. Immunol. 84: 273 1960;
  • 41 Christian C. L. Studies of aggregated gammaglobulin. I. Sedimentation, electrophoretic and anticomplementary properties. J. Immunol. 84: 112 1960;
  • 42 Barandun S, Kistler P, Jeunet F, Isliker H. Intravenous administration of human gammaglobulin. Vox Sang. 7: 157 1962;
  • 43 Isliker H, Jacot-Guillarmod H, Waldesbühl M, Fellenberg R. V, Cerottini J. C. Complement fixation by different IgG preparations and fragments. In: 5th Int. Symp. on Immunopathology. Edited by Miescher P. A, and Grabar P. 197. Grune and Stratton, Inc.; New York: 1967
  • 44 Bernhard G. C, Cheng W, Talmage D. W. The reaction of rheumatoid factor and complement with γ-globulin coated latex. J. Immunol. 88: 750 1962;
  • 45 Brine K. L, Wedgwood R. J, Clark W. S. The effects of serum complement and its components on the rheumatoid latex fixation test. Arthr. and Rheum. 1: 230 1958;
  • 46 Ewald R. W, Schubart A. F. Agglutinating activity of the complement component C’1q in the F-II latex fixation test. J. Immunol. 97: 100 1966;
  • 47 Marcus D. M. On the interaction of complement and gammaglobulin. Fed. Proc. 18: 583 1959;
  • 48 Rytel M. W, Stollerman G. H. The opsonic effect of complement on the phagocytosis of gammaglobulin coated bentonite particles. J. Immunol. 90: 607 1963;
  • 49 McCarty D. J, Hogan J. M. Inflammatory reaction after intrasynovial injection of micro-crystalline adrenocorticosteroid esters. Arthr. and Rheum. 7: 359 1964;
  • 50 Ishizaka K. Gammaglobulin and molecular mechanisms in hypersensitivity reactions. Progr. Allergy 7: 32 1963;
  • 51 Ishizaka K, Campbell D. H. V. Change of optical rotation by the formation of skin reactive complexes. J. Immunol. 83: 318 1959;
  • 52 Ishizaka K, Ishizaka T. Biological activities of aggregated gammaglobulin. IL A study of various methods for aggregation and species differences. J. Immunol. 85: 163 1960;
  • 53 Costanzi J. J, Goltman G. A, Donaldson V. H. Activation of complement by a monoclonal cryoglobulin associated with cold urticaria. J. Lab. clin. Med. 70: 988 1967;
  • 54 Stroud R. M, Gontrell J. W. Interaction of aggregates of reduced insulin with gammaglobulin and complement. A pathogenetic hypothesis. Proc. Soc. exp. Biol. (N.Y.) 130: 501 1969;
  • 55 Forsgren A, Sjöquist J. “Protein A” from S.Aureus. I. Pseudo-immune reaction with human γ-globulin. J. Immunol. 97: 822 1966;
  • 56 Gustafson G. T, Sjöquist J, Stålenheim G. Protein A from staphylococcus aureus. II. Arthus-like reaction produced in rabbits by interaction of protein A and human γ-globulin. J. Immunol. 98: 1178 1967;
  • 57 Cochrane C. G. The Arthus reaction. In: The Inflammatory Process. Edited by Zweifach B. W, Grant L, and McGluskey R. T. 613. Academic Press Inc.; New York and London: 1965
  • 58 Dixon F. J. The role of antigen-antibody complexes in disease. Harvey Lect. 58: 21 1963;
  • 59 Ishizaka T, Ishizaka K. Biological activity of aggregated gammaglobulin. V. Agglutination of erythrocytes and platelets. J. Immunol. 89: 709 1962;
  • 60 Bettex-Gotland M, Lüscher E. F. Untersuchungen über die Auslösung der viskosen Metamorphose der menschlichen Blutplättchen durch Immunkomplexe. Path, et Microbiol. 27: 533 1964;
  • 61 Lüscher E. F. Les mécanismes de l’activation des plaquettes sanguines. Path, et Biol. 14: 224 1966;
  • 62 Miescher P, Cooper N. The fixation of soluble antigen-antibody complexes upon thrombocytes. Vox Sang. 5: 138 1960;
  • 63 Siqueira M, Nelson R. A. Platelet agglutination by immune complexes and its possible role in hypersensitivity. J. Immunol. 86: 516 1961;
  • 64 Shulman N. R. Immunoreactions involving platelets. III. Quantitative aspects of platelet agglutination, inhibition of clot retraction, and other reactions caused by the antibody of qui-nidine purpura. J. exp. Med. 107: 697 1958;
  • 65 Horowitz H. I, Des Prez R. M, Hook E. W. Effects of bacterial endotoxin on rabbit platelets. II. Enhancement of platelet factor 3 (PF-3) activity in vitro and in vivo. J. exp. Med. 116: 619 1962;
  • 66 Des Prez R. M, Horowitz H. I, Hook E. W. Effects of bacterial endotoxin on rabbit platelets. I. Platelet aggregation and release of platelet factors in vitro . J. exp. Med. 114: 857 1961;
  • 67 Des Prez R. M. The effect of bacterial endotoxin on rabbit platelets. V. Heat labile plasma factor requirements of endotoxin-induced platelet injury. J. Immunol. 99: 966 1967;
  • 68 Ream V. J, Deykin D, Gurewich V, Wessler S. The aggregation of human platelets by bacterial endotoxin. J. Lab. clin. Med. 66: 245 1965;
  • 69 Spielvogel A. R. An ultrastructural study of the mechanisms of platelet-endotoxin interactions. Blood 28: 985 1966;
  • 70 Walsh R. T, Barnhart M. I. Canine platelet responsesto zymosan. J. retic. Soc. 5: 591 1968;
  • 71 Henson P. M, Cochrane G. G. Immunological induction of increased vascular permeability. II. Two mechanisms of histamine release from rabbit platelets involving complement. J. exp. Med. 129: 167 1969;
  • 72 Bladen H. A, Gewurz H, Mergenhagen S. E. Interactions of the complement system with the surface and endotoxic lipopolysaccharide of veillonella alcalescens. J. exp. Med. 125: 767 1967;
  • 73 Gewurz H, Mergenhagen S. E, Nowotny A, Phillips J. K. Interactions of the complement system with native and chemically modified endotoxins. J. Bact. 95: 397 1968;
  • 74 Naff G. B, Byers P. H. Possible implication of complement in gout. J. clin. Invest. 46: 1099 1967;
  • 75 Pillemer L, Blum L, Lepow I. H, Ross D. A, Todd E. W, Wardlaw A. G. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 120: 279 1954;
  • 76 Ward P. A, Cochrane C. G, Muller-Eberhard H. J. The role of serum complement in Chemotaxis of leucocytes in vitro. J. exp. Med. 122: 327 1965;
  • 77 Jobin F, Tremblay F. Platelet reactions and immune processes. II. The inhibition of platelet aggregation by complement inhibitors. Thrombos. Diath. haemorrh. (Stuttg.) 22: 466 1969;
  • 78 Henson P. M. The adherence of leucocytes and platelets induced by fixed IgG antibody or complement. Immunology 16: 107 1969;
  • 79 Henney C. S, Ishizaka K. Heterogeneity in antibodies specific for aggregated human γ-globulin. J. Immunol. 101: 79 1968;
  • 80 Stetson C. A. In discussion. In: Mechanism of cell and tissue damage produced by immune reactions. In 2nd Int. Symp. on Immunopathology. Edited by Grabar P, and Miescher P. A. 285. Benno Schwabe & Co.; Basel: 1961
  • 81 Bozicevich J, Bunim J. J, Freund J, Ward S. Bentonite flocculation test for rheumatoid arthritis. Proc. Soc. exp. Biol. (N. Y.) 97: 180 1958;
  • 82 Potter E. V, Stollerman G. H. The opsonization of bentonite particles by γ-globulin. J. Immunol. 87: 110 1961;
  • 83 Gottlieb C. W, Lau K. S, Herbert V. Immunologic studies using antigen-coated charcoal: application to rheumatoid factor (RF). Arthr. and Rheum. 10: 199 1967;
  • 84 Kojima M, Imai Y. Mechanism of phagocytosis of the reticuloendothelial cells. Tohoku J. exp. Med. 76: 161 1962;
  • 85 Singer J. M, Plotz C. M. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Amer. J. Med. 21: 888 1956;
  • 86 Kochwa S, Brownnell M, Rosenfield R. E, Wasserman L. R. Adsorption of proteins by polystyrene particles. I. Molecular unfolding and acquired immunogenicity of IgG. J. Immunol. 92: 981 1967;
  • 87 Pernis B, Vigliani E. C, Hever A. E, Cavagna G. M. The production of rheumatoid factors in experimental animals. Folia Allergol. 10: 396 1963;